Skip to main content
Top
Published in: BMC Ophthalmology 1/2017

Open Access 01-12-2017 | Case report

Case report: bilateral Mooren ulcer in association with hepatitis C

Authors: Vesa Aaltonen, Mari Alavesa, Laura Pirilä, Eija Vesti, Mohammad Al-Juhaish

Published in: BMC Ophthalmology | Issue 1/2017

Login to get access

Abstract

Background

Mooren ulcer has been considered as an idiopathic autoimmune keratitis. However, it has been in some cases suggested to be associated with hepatitis C, although the evidence is very vague.

Case presentation

We present a case of a man who was diagnosed with a primary Mooren ulcer in his right eye. The eye became blind despite of intensive treatment with local medications and extensive surgical procedures. After 10 years, the patient was diagnosed with the same disease, now in his left, previously healthy eye. There was no history that would suggest a secondary Mooren ulcer, but a chronic hepatitis C infection was detected. Treatment was targeted against hepatitis C (ribavirin and interferon) in addition to immunosuppressive medical and surgical treatment which resulted in a full and more than 6 years lasting remission of the disease.

Conclusions

Whether the immunomodulatory and immunosuppressive medication against hepatitis C was the key reason for the good results in the treatment of the second eye, remains elusive. The causality of hepatitis C with respect to the pathogenesis of Mooren ulcer on this patient remains open, but should be considered as one of the possible etiological factors of the disease.
Literature
1.
go back to reference Srinivasan M, Zegans ME, Zelefscky JR, Kundu A, Lietman T, Whitcher JP, et al. Clinical characteristics of Mooren’s ulcer in South India. Br J Ophthalmol. 2007;5:570–5.CrossRef Srinivasan M, Zegans ME, Zelefscky JR, Kundu A, Lietman T, Whitcher JP, et al. Clinical characteristics of Mooren’s ulcer in South India. Br J Ophthalmol. 2007;5:570–5.CrossRef
2.
go back to reference Wilson SE, Lee WM, Murakami C, Weng J, Moninger GA. Mooren’s corneal ulcer and hepatitis virus infection (letter). N Engl J Med. 1993;329:62.CrossRefPubMed Wilson SE, Lee WM, Murakami C, Weng J, Moninger GA. Mooren’s corneal ulcer and hepatitis virus infection (letter). N Engl J Med. 1993;329:62.CrossRefPubMed
3.
go back to reference Wilson SE, Lee WM, Murakami C, Weng J, Moninger GA. Mooren-type hepatitis C virus-associated corneal ulceration. Ophthalmology. 1994;101:736–45.CrossRefPubMed Wilson SE, Lee WM, Murakami C, Weng J, Moninger GA. Mooren-type hepatitis C virus-associated corneal ulceration. Ophthalmology. 1994;101:736–45.CrossRefPubMed
4.
go back to reference Moazami G, Auran JD, Florakis GJ, Wilson SE, Srinivasan DB. Interferon treatment of Mooren's ulcers associated with hepatitis C. Am J Ophthalmol. 1995;119:365–6.CrossRefPubMed Moazami G, Auran JD, Florakis GJ, Wilson SE, Srinivasan DB. Interferon treatment of Mooren's ulcers associated with hepatitis C. Am J Ophthalmol. 1995;119:365–6.CrossRefPubMed
5.
go back to reference Pluznik D, Butrus SI. Hepatitis C-associated peripheral corneal ulceration. Rapid response to intravenous steroids. Cornea. 2001;20:888–9.CrossRefPubMed Pluznik D, Butrus SI. Hepatitis C-associated peripheral corneal ulceration. Rapid response to intravenous steroids. Cornea. 2001;20:888–9.CrossRefPubMed
6.
go back to reference Kafkala C, Choi J, Zafirakis P, Baltatzis S, Livir-Rallatos C, Rojas B, et al. Mooren ulcer: an immunopathologic study. Cornea. 2006;25:667–73.CrossRefPubMed Kafkala C, Choi J, Zafirakis P, Baltatzis S, Livir-Rallatos C, Rojas B, et al. Mooren ulcer: an immunopathologic study. Cornea. 2006;25:667–73.CrossRefPubMed
7.
go back to reference Tandon R, Chawla B, Verma K, Sharma N, Titiyal JS. Outcome of treatment of mooren ulcer with topical cyclosporine a 2%. Cornea. 2008;27:859–61.CrossRefPubMed Tandon R, Chawla B, Verma K, Sharma N, Titiyal JS. Outcome of treatment of mooren ulcer with topical cyclosporine a 2%. Cornea. 2008;27:859–61.CrossRefPubMed
8.
go back to reference Tsoumani A, Theopistos V, Katsanos K, Asproudis I, Tsianos EV. Treatment and non-treatment related ocular manifestations in patients with chronic hepatitis B or C. Eur Rev Med Pharmacol Sci. 2013;17:1123–31.PubMed Tsoumani A, Theopistos V, Katsanos K, Asproudis I, Tsianos EV. Treatment and non-treatment related ocular manifestations in patients with chronic hepatitis B or C. Eur Rev Med Pharmacol Sci. 2013;17:1123–31.PubMed
9.
go back to reference Sangwan VS, Zafirakis P, Foster CS. Mooren’s ulcer: current conceps in management. Indian J Ophthalmol. 1997;45:7–17.PubMed Sangwan VS, Zafirakis P, Foster CS. Mooren’s ulcer: current conceps in management. Indian J Ophthalmol. 1997;45:7–17.PubMed
10.
go back to reference Dana MR, Qian Y, Hamrah P. Twenty-five-year panorama of corneal immunology: emerging concepts in the immunopathogenesis of microbial keratitis, peripheral ulcerative keratitis, and corneal transplant rejection. Cornea. 2000;19:625–43.CrossRefPubMed Dana MR, Qian Y, Hamrah P. Twenty-five-year panorama of corneal immunology: emerging concepts in the immunopathogenesis of microbial keratitis, peripheral ulcerative keratitis, and corneal transplant rejection. Cornea. 2000;19:625–43.CrossRefPubMed
11.
go back to reference Erdem U, Kerimoglu H, Gundogan FC, Dagli S. Treatment of Mooren’s ulcer with topical administration of interferon alfa 2a. Ophthalmology. 2007;114:446–9.CrossRefPubMed Erdem U, Kerimoglu H, Gundogan FC, Dagli S. Treatment of Mooren’s ulcer with topical administration of interferon alfa 2a. Ophthalmology. 2007;114:446–9.CrossRefPubMed
Metadata
Title
Case report: bilateral Mooren ulcer in association with hepatitis C
Authors
Vesa Aaltonen
Mari Alavesa
Laura Pirilä
Eija Vesti
Mohammad Al-Juhaish
Publication date
01-12-2017
Publisher
BioMed Central
Published in
BMC Ophthalmology / Issue 1/2017
Electronic ISSN: 1471-2415
DOI
https://doi.org/10.1186/s12886-017-0633-x

Other articles of this Issue 1/2017

BMC Ophthalmology 1/2017 Go to the issue